Доклад с 15 Межрегиональной научно-практической конференции "Искусственное питание и инфузионная терапия больных в медицине критических состояний" 21-22 мая 2015 г
The liver and gut have extensive embryological, anatomical, physiological, and pathophysiological interrelations. Embryologically, the liver arises from the foregut. Anatomically, the liver receives blood from the digestive tract and excretes bile into the small intestine. Physiologically, bile aids in fat digestion and the enterohepatic circulation recycles bile acids. Disorders can involve defects in bile acid synthesis, transport, bacterial transformation, or circulation between organs. The liver and gut extensively influence each other's function and disease states.
This document provides an overview of enterocutaneous fistulas (ECF), including their classification, etiology, prognosis, investigations, and management. ECF are abnormal connections between the bowel and skin that can form after surgery or trauma. They are classified based on output and can be caused by postoperative complications, trauma, or spontaneous events like malignancy or Crohn's disease. Prognosis depends on factors like output, nutrition, and the state of the bowel and adjacent tissue. Management focuses on treating sepsis, maintaining nutrition via enteral or parenteral routes, protecting the skin, and planning surgical repair once the patient is stabilized.
This document discusses the management of enterocutaneous fistulas (ECF). The goals of management are to control sepsis, provide nutritional support, define the intestinal anatomy, and develop a surgical procedure. Investigations such as fistulography and imaging modalities are used to characterize the fistula. Nutritional support may involve enteral or parenteral nutrition depending on the location and output of the fistula. Controlling drainage and skin care is important for wound healing. Surgical intervention is considered if non-operative measures fail.
Interstitial Cystitis (IC) is a chronic bladder condition characterized by pelvic pain and urinary urgency and frequency. The cause is unknown but may involve defects in the bladder lining. It predominantly affects women and symptoms can worsen premenstrually. Diagnosis involves patient history, physical exam, cystoscopy and ruling out other causes. Treatment progresses from behavioral modifications and physical therapy to medications, hydrodistension, nerve stimulation and rarely surgery. The goal is a multimodal approach to manage symptoms, with conservative treatments tried before more invasive options.
This document discusses functional constipation. It provides the Rome IV diagnostic criteria for functional constipation which includes symptoms like straining, hard stools, sensation of incomplete evacuation occurring in over 25% of bowel movements. It notes that loose stools are rarely present without laxative use. Therapeutic options for functional constipation are discussed including fiber, PEG, linaclotide, prucalopride, and lubiprostone. A diagnostic and therapeutic algorithm is proposed. Risk factors for anorectal pathology after pregnancy are also discussed.
This document discusses peptic ulcer disease and Helicobacter pylori infection. It provides details on the anatomy and physiology of acid secretion in the stomach. It describes the clinical features, diagnosis, and treatment of peptic ulcers including the roles of proton pump inhibitors, H2 receptor antagonists, and antibiotic therapies. It discusses H. pylori infection as a major cause of peptic ulcers and outlines tests to diagnose infection and various antibiotic regimens used for eradication treatment.
The liver and gut have extensive embryological, anatomical, physiological, and pathophysiological interrelations. Embryologically, the liver arises from the foregut. Anatomically, the liver receives blood from the digestive tract and excretes bile into the small intestine. Physiologically, bile aids in fat digestion and the enterohepatic circulation recycles bile acids. Disorders can involve defects in bile acid synthesis, transport, bacterial transformation, or circulation between organs. The liver and gut extensively influence each other's function and disease states.
This document provides an overview of enterocutaneous fistulas (ECF), including their classification, etiology, prognosis, investigations, and management. ECF are abnormal connections between the bowel and skin that can form after surgery or trauma. They are classified based on output and can be caused by postoperative complications, trauma, or spontaneous events like malignancy or Crohn's disease. Prognosis depends on factors like output, nutrition, and the state of the bowel and adjacent tissue. Management focuses on treating sepsis, maintaining nutrition via enteral or parenteral routes, protecting the skin, and planning surgical repair once the patient is stabilized.
This document discusses the management of enterocutaneous fistulas (ECF). The goals of management are to control sepsis, provide nutritional support, define the intestinal anatomy, and develop a surgical procedure. Investigations such as fistulography and imaging modalities are used to characterize the fistula. Nutritional support may involve enteral or parenteral nutrition depending on the location and output of the fistula. Controlling drainage and skin care is important for wound healing. Surgical intervention is considered if non-operative measures fail.
Interstitial Cystitis (IC) is a chronic bladder condition characterized by pelvic pain and urinary urgency and frequency. The cause is unknown but may involve defects in the bladder lining. It predominantly affects women and symptoms can worsen premenstrually. Diagnosis involves patient history, physical exam, cystoscopy and ruling out other causes. Treatment progresses from behavioral modifications and physical therapy to medications, hydrodistension, nerve stimulation and rarely surgery. The goal is a multimodal approach to manage symptoms, with conservative treatments tried before more invasive options.
This document discusses functional constipation. It provides the Rome IV diagnostic criteria for functional constipation which includes symptoms like straining, hard stools, sensation of incomplete evacuation occurring in over 25% of bowel movements. It notes that loose stools are rarely present without laxative use. Therapeutic options for functional constipation are discussed including fiber, PEG, linaclotide, prucalopride, and lubiprostone. A diagnostic and therapeutic algorithm is proposed. Risk factors for anorectal pathology after pregnancy are also discussed.
This document discusses peptic ulcer disease and Helicobacter pylori infection. It provides details on the anatomy and physiology of acid secretion in the stomach. It describes the clinical features, diagnosis, and treatment of peptic ulcers including the roles of proton pump inhibitors, H2 receptor antagonists, and antibiotic therapies. It discusses H. pylori infection as a major cause of peptic ulcers and outlines tests to diagnose infection and various antibiotic regimens used for eradication treatment.
This document discusses the management of enterocutaneous fistulas. Key points include:
- Enterocutaneous fistulas are abnormal connections between the bowel and skin that can have mortality rates up to 21%.
- Management involves stabilization, investigation to determine fistula characteristics, deciding on a treatment plan, and definitive management through surgery or allowing for spontaneous closure.
- Nutritional management is essential, involving enteral or parenteral nutrition depending on fistula output to support healing and potential spontaneous closure. Surgical treatment is considered if the fistula is unlikely to close spontaneously.
Interstitial cystitis , a debilitating condition has been impairing the quality of life amongst the patients . It is fast a gaining a status of disability due to its life crippling symptoms and the pain associated with the condition
Short bowel syndrome (SBS) results from insufficient intestinal length to support nutrient absorption. It can be defined anatomically as less than 200cm of small bowel length in adults or less than 100-150cm without the colon. The main causes in developing countries are typhoid, intestinal atresias and complications of abdominal surgeries. Management involves nutritional support, medications to reduce diarrhea, and surgical procedures to increase bowel length or function. Advances include intestinal lengthening procedures and intestinal transplantation, but prevention through early management of conditions causing bowel loss remains important.
Discuss the Pathology and Management of Short Bowel Syndrome presentationOladele Situ
Short bowel syndrome (SBS) results from insufficient intestinal length to support nutritional needs. It can be defined anatomically as less than 200cm of small bowel length or functionally by the clinical manifestations of diarrhea, dehydration and malnutrition. Management involves medical therapy with nutritional supplementation, medications to reduce diarrhea, and surgical procedures to increase bowel length or function. Advances include serial transverse enteroplasty and intestinal transplantation. The goal is to improve patients' nutrition and quality of life through the safest and most effective treatment options. Prevention remains important to reducing the burden of this condition.
This document discusses infantile hypertrophic pyloric stenosis (IHPS). It begins with an overview of stomach anatomy and the function of the pylorus. It then covers the epidemiology, etiology, risk factors, clinical presentation, diagnosis, differential diagnosis, and management of IHPS. Management involves preoperative correction of dehydration and electrolyte abnormalities followed by pyloromyotomy, which can be performed via open or laparoscopic surgery. The open approach involves a longitudinal incision and division of the pyloric muscle fibers.
This document discusses chronic pancreatitis, including its definition, causes, symptoms, diagnostic tests, and surgical treatment options. It notes that chronic pancreatitis is characterized by irreversible morphological changes and permanent loss of pancreatic function. The main indications for surgery are intractable pain and complications. Surgical options include drainage procedures like longitudinal pancreaticojejunostomy or cyst-enterostomies, as well as resections like Whipple procedure or distal pancreatectomy. The goals of surgery are pain relief, control of complications, and improved quality of life. While surgery provides sustained pain relief in over 85% of patients, outcomes may be complicated by associated issues like portal hypertension.
This document provides an overview of peptic ulcer disease (PUD) and its management. It discusses the types and causes of PUD, including Helicobacter pylori infection and NSAID use. Complications of PUD like bleeding, perforation, and obstruction are also covered. The management of PUD focuses on medical treatment with acid suppressants, H. pylori eradication therapy, and long-term maintenance to prevent recurrence. Surgical treatment may be needed for complications that do not respond to medical management.
Chronic pancreatitis is a long-term inflammation of the pancreas that results in permanent damage. The patient, AH, underwent a Whipple procedure for chronic pancreatitis caused by hypertriglyceridemia and possible bile duct stones. Over her 7 day hospital stay, AH's diet was advanced from NPO to regular meals. She was educated on GI and diabetes diets and discharged tolerating a regular diet.
The document discusses enterocutaneous fistulas (ECF), abnormal connections between the gastrointestinal tract and skin. ECF are commonly caused by surgery (75-85%) and the ileum is the most common origin site. Diagnosis is clinical with imaging to identify anatomy and rule out abscesses. Treatment involves stabilization, sepsis control, nutrition, and identifying the fistula anatomy. Most ECF close spontaneously with conservative management including nutrition support. Surgery is considered if the fistula does not close within 3-6 months.
Case Presentation on Perforated Duodenal Ulcerksaigowtham
a case study in the department of general medicine surgery which was collected in the month of November 2019 and studied analyzed with SOAP format and submitted
This document provides an overview of the history and treatment of peptic ulcer disease. It begins with definitions and presentations of gastric and duodenal ulcers. It then discusses early theories on the causes of ulcers and various surgical treatments attempted over time. A major breakthrough was the discovery of Helicobacter pylori in 1982 and understanding its role in ulcer development. Current treatment focuses on eradication of H. pylori with antibiotic therapies. The document traces the evolving understanding of peptic ulcers from early theories to current microbiological causes.
This document discusses various treatments for chronic pancreatitis including enzyme supplementation, analgesics, surgery, and islet cell transplantation. It provides details on different surgical procedures like the Kausch-Whipple procedure, Frey's procedure, and variants such as the Bern modification. The rationale for islet cell transplantation is described as removing the inflamed organ while preventing type 3c diabetes. Outcomes of different surgical techniques are compared, noting that combining resection and drainage is generally better than pure drainage procedures.
Peptic Ulcer Saint James School of Medicine bimmerque
This document discusses peptic ulcer disease and its treatment. It begins by presenting a case of a 43-year-old man diagnosed with peptic ulcers after presenting with epigastric pain. He is started on medication that inhibits the proton pump in the stomach. Peptic ulcer disease affects over 6 million Americans each year and is often caused by H. pylori infection or NSAID use. Treatment involves eradicating the underlying cause, reducing stomach acid with proton pump inhibitors or H2 blockers, and managing complications like bleeding. Endoscopy may be used for diagnosis and treatment.
This document provides information about small intestine transplantation, including:
- Types of intestinal transplants include isolated small intestine transplants (IITx), liver-intestinal transplants (L-Itx), and multivisceral transplants (MVTx).
- Indications for intestinal transplants include intestinal failure from short bowel syndrome or motility disorders, as well as liver failure from long-term parenteral nutrition.
- Surgical techniques involve mobilizing the small intestine and associated vasculature from the donor, and implanting it into the recipient by anastomosing the donor and recipient vessels.
- Pre-operative evaluation and donor selection aim to minimize risks of infection, rejection and complications.
This document discusses peptic ulcers, including their causes, symptoms, diagnosis, and treatment. Peptic ulcers are abnormalities in the gastrointestinal tract caused by damage from stomach acid. The most common causes are infection with Helicobacter pylori bacteria and long-term use of nonsteroidal anti-inflammatory drugs. Common symptoms include abdominal pain, nausea, and vomiting of blood. Diagnosis involves tests to detect H. pylori infection and endoscopy to view the ulcers. Treatment focuses on eradicating H. pylori with antibiotics, reducing stomach acid with proton pump inhibitors or H2 blockers, and protecting the lining with sucralfate.
- A 59-year-old female with a history of liver cirrhosis and previous surgeries presented with abdominal distension and was diagnosed with Ogilvie syndrome after imaging found colon dilation.
- Ogilvie syndrome, also called acute colonic pseudo-obstruction, occurs when the colon becomes dilated without a mechanical blockage due to autonomic nervous system dysfunction.
- It is usually caused by recent surgery, illness, or medications and carries risks of perforation if not decompressed. Treatment options include conservative measures, neostigmine to stimulate motility, or surgical decompression through cecostomy or colectomy.
The document discusses peptic ulcers, including that the prevalence in India is estimated at 4-10 per 1000 people aged 30-60, with males at higher risk. Common causes are H. pylori infection, smoking, alcohol, NSAIDs, and stress. Symptoms include abdominal pain relieved by food as well as bleeding. Diagnosis involves tests like endoscopy. Treatment focuses on eliminating H. pylori, reducing acid secretion, and lifestyle changes. Complications can include hemorrhage, perforation, and obstruction.
This document discusses the management of small intestinal fistulae. It notes that fistulae can be classified as congenital or acquired, external or internal. Primary fistulae are caused by an underlying gut wall disease while secondary fistulae occur after injury. Outcomes depend on factors like fistula type (simple vs complex), output (high vs low), nutrition status, and presence of sepsis. Management involves resuscitation, nutrition support, delineating anatomy, and either allowing spontaneous closure or surgical closure. Surgical closure is often staged and aims to drain sepsis, resect diseased bowel, and reconstruct the GI tract. Complications can include recurrent fistulae or short bowel syndrome.
This document provides an overview of the management of gastrointestinal disorders. It begins with the anatomy and physiology of the digestive system and then discusses diagnostic examinations for GI disorders. Specific disorders of the upper GI tract are reviewed including GERD, hiatal hernia, esophageal cancer, and impaired esophageal motility. Disorders of the stomach and duodenum such as gastritis, peptic ulcer disease, and stomach cancer are also examined. The document then covers lower GI disorders like irritable bowel syndrome, inflammatory bowel disease including Crohn's disease and ulcerative colitis, and acute inflammatory intestinal disorders like appendicitis. Treatment options including medications, diet, and surgery are described for each condition.
This document discusses enteral and parenteral nutrition. It begins by describing enteral nutrition, including types of enteral delivery such as oral diet or tube feeding. It then discusses indications, advantages, and effects of enteral nutrition on gut microbiota. Various techniques for enteral access like gastrostomy and jejunostomy are described. The document then discusses parenteral nutrition, including types like total or peripheral parenteral nutrition. Methods for calculating nutrient requirements and formulations for parenteral nutrition are provided. Complications of both enteral and parenteral nutrition are also summarized.
The document discusses nutritional considerations for three clinical scenarios involving critically ill patients, including guidelines for determining nutritional needs, initiating enteral or parenteral nutrition, monitoring patients on nutrition support, and potential complications. It also addresses factors such as appropriate tube feeding routes and formulas based on patient conditions.
This document discusses the management of enterocutaneous fistulas. Key points include:
- Enterocutaneous fistulas are abnormal connections between the bowel and skin that can have mortality rates up to 21%.
- Management involves stabilization, investigation to determine fistula characteristics, deciding on a treatment plan, and definitive management through surgery or allowing for spontaneous closure.
- Nutritional management is essential, involving enteral or parenteral nutrition depending on fistula output to support healing and potential spontaneous closure. Surgical treatment is considered if the fistula is unlikely to close spontaneously.
Interstitial cystitis , a debilitating condition has been impairing the quality of life amongst the patients . It is fast a gaining a status of disability due to its life crippling symptoms and the pain associated with the condition
Short bowel syndrome (SBS) results from insufficient intestinal length to support nutrient absorption. It can be defined anatomically as less than 200cm of small bowel length in adults or less than 100-150cm without the colon. The main causes in developing countries are typhoid, intestinal atresias and complications of abdominal surgeries. Management involves nutritional support, medications to reduce diarrhea, and surgical procedures to increase bowel length or function. Advances include intestinal lengthening procedures and intestinal transplantation, but prevention through early management of conditions causing bowel loss remains important.
Discuss the Pathology and Management of Short Bowel Syndrome presentationOladele Situ
Short bowel syndrome (SBS) results from insufficient intestinal length to support nutritional needs. It can be defined anatomically as less than 200cm of small bowel length or functionally by the clinical manifestations of diarrhea, dehydration and malnutrition. Management involves medical therapy with nutritional supplementation, medications to reduce diarrhea, and surgical procedures to increase bowel length or function. Advances include serial transverse enteroplasty and intestinal transplantation. The goal is to improve patients' nutrition and quality of life through the safest and most effective treatment options. Prevention remains important to reducing the burden of this condition.
This document discusses infantile hypertrophic pyloric stenosis (IHPS). It begins with an overview of stomach anatomy and the function of the pylorus. It then covers the epidemiology, etiology, risk factors, clinical presentation, diagnosis, differential diagnosis, and management of IHPS. Management involves preoperative correction of dehydration and electrolyte abnormalities followed by pyloromyotomy, which can be performed via open or laparoscopic surgery. The open approach involves a longitudinal incision and division of the pyloric muscle fibers.
This document discusses chronic pancreatitis, including its definition, causes, symptoms, diagnostic tests, and surgical treatment options. It notes that chronic pancreatitis is characterized by irreversible morphological changes and permanent loss of pancreatic function. The main indications for surgery are intractable pain and complications. Surgical options include drainage procedures like longitudinal pancreaticojejunostomy or cyst-enterostomies, as well as resections like Whipple procedure or distal pancreatectomy. The goals of surgery are pain relief, control of complications, and improved quality of life. While surgery provides sustained pain relief in over 85% of patients, outcomes may be complicated by associated issues like portal hypertension.
This document provides an overview of peptic ulcer disease (PUD) and its management. It discusses the types and causes of PUD, including Helicobacter pylori infection and NSAID use. Complications of PUD like bleeding, perforation, and obstruction are also covered. The management of PUD focuses on medical treatment with acid suppressants, H. pylori eradication therapy, and long-term maintenance to prevent recurrence. Surgical treatment may be needed for complications that do not respond to medical management.
Chronic pancreatitis is a long-term inflammation of the pancreas that results in permanent damage. The patient, AH, underwent a Whipple procedure for chronic pancreatitis caused by hypertriglyceridemia and possible bile duct stones. Over her 7 day hospital stay, AH's diet was advanced from NPO to regular meals. She was educated on GI and diabetes diets and discharged tolerating a regular diet.
The document discusses enterocutaneous fistulas (ECF), abnormal connections between the gastrointestinal tract and skin. ECF are commonly caused by surgery (75-85%) and the ileum is the most common origin site. Diagnosis is clinical with imaging to identify anatomy and rule out abscesses. Treatment involves stabilization, sepsis control, nutrition, and identifying the fistula anatomy. Most ECF close spontaneously with conservative management including nutrition support. Surgery is considered if the fistula does not close within 3-6 months.
Case Presentation on Perforated Duodenal Ulcerksaigowtham
a case study in the department of general medicine surgery which was collected in the month of November 2019 and studied analyzed with SOAP format and submitted
This document provides an overview of the history and treatment of peptic ulcer disease. It begins with definitions and presentations of gastric and duodenal ulcers. It then discusses early theories on the causes of ulcers and various surgical treatments attempted over time. A major breakthrough was the discovery of Helicobacter pylori in 1982 and understanding its role in ulcer development. Current treatment focuses on eradication of H. pylori with antibiotic therapies. The document traces the evolving understanding of peptic ulcers from early theories to current microbiological causes.
This document discusses various treatments for chronic pancreatitis including enzyme supplementation, analgesics, surgery, and islet cell transplantation. It provides details on different surgical procedures like the Kausch-Whipple procedure, Frey's procedure, and variants such as the Bern modification. The rationale for islet cell transplantation is described as removing the inflamed organ while preventing type 3c diabetes. Outcomes of different surgical techniques are compared, noting that combining resection and drainage is generally better than pure drainage procedures.
Peptic Ulcer Saint James School of Medicine bimmerque
This document discusses peptic ulcer disease and its treatment. It begins by presenting a case of a 43-year-old man diagnosed with peptic ulcers after presenting with epigastric pain. He is started on medication that inhibits the proton pump in the stomach. Peptic ulcer disease affects over 6 million Americans each year and is often caused by H. pylori infection or NSAID use. Treatment involves eradicating the underlying cause, reducing stomach acid with proton pump inhibitors or H2 blockers, and managing complications like bleeding. Endoscopy may be used for diagnosis and treatment.
This document provides information about small intestine transplantation, including:
- Types of intestinal transplants include isolated small intestine transplants (IITx), liver-intestinal transplants (L-Itx), and multivisceral transplants (MVTx).
- Indications for intestinal transplants include intestinal failure from short bowel syndrome or motility disorders, as well as liver failure from long-term parenteral nutrition.
- Surgical techniques involve mobilizing the small intestine and associated vasculature from the donor, and implanting it into the recipient by anastomosing the donor and recipient vessels.
- Pre-operative evaluation and donor selection aim to minimize risks of infection, rejection and complications.
This document discusses peptic ulcers, including their causes, symptoms, diagnosis, and treatment. Peptic ulcers are abnormalities in the gastrointestinal tract caused by damage from stomach acid. The most common causes are infection with Helicobacter pylori bacteria and long-term use of nonsteroidal anti-inflammatory drugs. Common symptoms include abdominal pain, nausea, and vomiting of blood. Diagnosis involves tests to detect H. pylori infection and endoscopy to view the ulcers. Treatment focuses on eradicating H. pylori with antibiotics, reducing stomach acid with proton pump inhibitors or H2 blockers, and protecting the lining with sucralfate.
- A 59-year-old female with a history of liver cirrhosis and previous surgeries presented with abdominal distension and was diagnosed with Ogilvie syndrome after imaging found colon dilation.
- Ogilvie syndrome, also called acute colonic pseudo-obstruction, occurs when the colon becomes dilated without a mechanical blockage due to autonomic nervous system dysfunction.
- It is usually caused by recent surgery, illness, or medications and carries risks of perforation if not decompressed. Treatment options include conservative measures, neostigmine to stimulate motility, or surgical decompression through cecostomy or colectomy.
The document discusses peptic ulcers, including that the prevalence in India is estimated at 4-10 per 1000 people aged 30-60, with males at higher risk. Common causes are H. pylori infection, smoking, alcohol, NSAIDs, and stress. Symptoms include abdominal pain relieved by food as well as bleeding. Diagnosis involves tests like endoscopy. Treatment focuses on eliminating H. pylori, reducing acid secretion, and lifestyle changes. Complications can include hemorrhage, perforation, and obstruction.
This document discusses the management of small intestinal fistulae. It notes that fistulae can be classified as congenital or acquired, external or internal. Primary fistulae are caused by an underlying gut wall disease while secondary fistulae occur after injury. Outcomes depend on factors like fistula type (simple vs complex), output (high vs low), nutrition status, and presence of sepsis. Management involves resuscitation, nutrition support, delineating anatomy, and either allowing spontaneous closure or surgical closure. Surgical closure is often staged and aims to drain sepsis, resect diseased bowel, and reconstruct the GI tract. Complications can include recurrent fistulae or short bowel syndrome.
This document provides an overview of the management of gastrointestinal disorders. It begins with the anatomy and physiology of the digestive system and then discusses diagnostic examinations for GI disorders. Specific disorders of the upper GI tract are reviewed including GERD, hiatal hernia, esophageal cancer, and impaired esophageal motility. Disorders of the stomach and duodenum such as gastritis, peptic ulcer disease, and stomach cancer are also examined. The document then covers lower GI disorders like irritable bowel syndrome, inflammatory bowel disease including Crohn's disease and ulcerative colitis, and acute inflammatory intestinal disorders like appendicitis. Treatment options including medications, diet, and surgery are described for each condition.
This document discusses enteral and parenteral nutrition. It begins by describing enteral nutrition, including types of enteral delivery such as oral diet or tube feeding. It then discusses indications, advantages, and effects of enteral nutrition on gut microbiota. Various techniques for enteral access like gastrostomy and jejunostomy are described. The document then discusses parenteral nutrition, including types like total or peripheral parenteral nutrition. Methods for calculating nutrient requirements and formulations for parenteral nutrition are provided. Complications of both enteral and parenteral nutrition are also summarized.
The document discusses nutritional considerations for three clinical scenarios involving critically ill patients, including guidelines for determining nutritional needs, initiating enteral or parenteral nutrition, monitoring patients on nutrition support, and potential complications. It also addresses factors such as appropriate tube feeding routes and formulas based on patient conditions.
1. An enterocutaneous fistula is an abnormal connection between the gastrointestinal tract and the skin that usually results from surgery or trauma. The ileum is the most common site of origin.
2. Factors that favor spontaneous closure include small defects, jejunal or colonic origins, and continuity of the gastrointestinal tract. Factors that discourage closure are the presence of inflammation, infection, obstruction, or malignancy.
3. Treatment involves stabilization, controlling sepsis, defining the anatomy, and planning definitive therapy, which is usually surgery to resect the involved segment after 6-12 weeks of management.
This document discusses the gallbladder, cholecystitis, acute pancreatitis, and a case study involving a 77-year-old female admitted with abdominal pain. It provides details on gallstones, the gallbladder, bile, pancreatitis, and treatments including cholecystectomy and enteral nutrition. Complications of pancreatitis like ARF, ARDS, and mortality risks are also reviewed. Popular stimulant drugs methamphetamines and bath salts are compared in terms of their effects, dangers, and side effects.
The document summarizes the normal changes that occur during the postpartum period known as the puerperium. Key points include:
- The puerperium lasts 6 weeks as the body returns to its pre-pregnancy state. The uterus involutes from 1 kg to 70g over this time.
- Lochia is vaginal discharge after delivery in 3 stages from red to white over 10-15 days. Abnormal lochia can indicate infection.
- Care during the puerperium involves ambulation, monitoring for pain/fever/pulse, diet, checking involution and lochia, bowel/bladder care, and breast/perineal care. Follow-
Hepatobiliary scintigraphy uses radiolabeled tracers like Tc-99m mebrofenin to evaluate liver function and bile flow. It is indicated for conditions like neonatal jaundice, bile leaks, and gallbladder disease. The tracer is taken up by hepatocytes and secreted into bile for imaging. Imaging involves static and dynamic acquisition over hours. Interpretation looks for normal tracer flow and any delays, leaks, or other abnormalities that could indicate underlying bile disorders.
The document discusses acute pancreatitis, including its definition, classification, etiologies, pathogenesis, clinical presentation, diagnosis, management, and complications. Acute pancreatitis is an inflammatory condition of the pancreas characterized by abdominal pain and elevated pancreatic enzymes. It is classified based on the extent of tissue necrosis and disease severity. Common causes include gallstones, alcohol use, and traumatic injury to the pancreas. Management involves conservative treatment like NPO, IV fluids, and antibiotics, with surgery reserved for complications like pancreatic necrosis or abscess formation.
Information about Acute pancreatitis by Dr Dhaval Mangukiya.
Details of Acute Pancreatitis Multidisciplinary Approach, Case Scenario, CT, Post Operative Course,
http://www.youtube.com/c/DrDhavalMangukiyaGastrosurgeonSurat
https://gastrosurgerysurat.blogspot.com/
https://drdhavalmangukiya.com/
This document discusses constipation, including its definition, diagnostic criteria, types, diagnosis and evaluation, approach, and management. It begins by defining constipation and its most common symptoms. It then discusses the Rome III and ACG diagnostic criteria. It describes the main types of constipation as primary (normal transit, slow transit, defecatory disorders) and secondary. Various diagnostic tests are outlined including colonic transit tests, anorectal manometry, and defecography. The approach prioritizes evaluating for secondary causes and alarming features. The role of endoscopy is to exclude conditions like cancer or Hirschsprung's disease. Management options discussed include lifestyle changes, fiber supplements, laxatives, newer drugs like lub
This document provides an overview of the concepts of elimination, including definitions, common problems, nursing assessments, and interventions. It discusses the normal functioning of the urinary and gastrointestinal systems and factors that can influence elimination patterns. Common urinary issues covered include urinary tract infections, incontinence, retention, and diversions. For the bowels, constipation, diarrhea, impaction, and incontinence are addressed. Nursing assessments and plans of care for both systems are outlined, along with health promotion strategies and acute and restorative nursing interventions.
Colostomy power point is very important for studentstembotisa26
This topic will help health worker to know what colostomy is and it will help them to have knowledge on the management of the patient with this condition
HIRSCHSPRUNG DISEASE of neonate wrr.pptxShambelNegese
disease is a condition that affects the large intestine (colon) and causes problems with passing stool. The condition is present at birth (congenital) as a result of missing nerve cells in the muscles of the baby's colon.
This document provides an overview of the management of enterocutaneous fistulas. It discusses the history, classification, etiology, pathophysiology, clinical presentation, investigation, management phases including stabilization, decision making, treatment, and prevention of enterocutaneous fistulas. The management involves correcting fluid and electrolyte imbalances, providing nutritional support, controlling sepsis, making a decision on definitive therapy after 4-6 weeks if not closing spontaneously, and surgical treatment when needed.
The document discusses defecation and constipation. It defines defecation as the process of passing stool through the anus, which is usually painless and under voluntary control. Constipation is defined as having less than 3 bowel movements per week and other symptoms like straining. Causes of constipation include low fiber diet, lack of exercise, and certain medications. Constipation can be primary/functional or secondary to other underlying disorders and is diagnosed based on symptoms and medical history.
1) An intestinal fistula is an abnormal connection between two epithelial surfaces, most commonly the intestine and skin (enterocutaneous). The ileum is the most common site of origin.
2) Fistulas can be classified anatomically by their connections or physiologically by their output. Enterocutaneous fistulas usually result from complications of intestinal surgery.
3) Management of intestinal fistulas involves stabilization of the patient through fluid resuscitation, nutritional support, and controlling sepsis before considering definitive surgical repair once the patient's condition has improved.
Managament of anastomotic leak - case capsule- Dr Keyur BhattDrKeyurBhattMSMRCSEd
Management of anastomotic leak after gastrointestinal surgery. This is very important step for any general or GI surgeons to know how to deal with the anastomotic leak following surgery.
"Нутриционная поддержка и реабилитация: врач-ребенок-мама" Коровина И.В.(Мос...rnw-aspen
Доклад с XVI Межрегиональной научно-практической конференции "Искусственное питание и инфузионная терапия больных в медицине критических состояний" 21-22 апреля 2016 г.
"Нутриционная поддержка детей с органическими поражениями головного мозга" З...rnw-aspen
Доклад с XVI Межрегиональной научно-практической конференции "Искусственное питание и инфузионная терапия больных в медицине критических состояний" 21-22 апреля 2016 г.
"Опыт организации группы нутритивной терапии в федеральном научно-клиническом...rnw-aspen
Доклад с XVI Межрегиональной научно-практической конференции "Искусственное питание и инфузионная терапия больных в медицине критических состояний" 21-22 апреля 2016 г.
"Нарушения нутритивного статуса и возможности его коррекции у пациентов после...rnw-aspen
Доклад с XVI Межрегиональной научно-практической конференции "Искусственное питание и инфузионная терапия больных в медицине критических состояний" 21-22 апреля 2016 г.
"Нутритивный статус у детей, подвергающихся трансплантации гемопоэтических ст...rnw-aspen
Доклад с XVI Межрегиональной научно-практической конференции "Искусственное питание и инфузионная терапия больных в медицине критических состояний" 21-22 апреля 2016 г.
"Распространенность и выраженность недостаточности питания среди пациентов ФН...rnw-aspen
Доклад с XVI Межрегиональной научно-практической конференции "Искусственное питание и инфузионная терапия больных в медицине критических состояний" 21-22 апреля 2016 г.
"Первый опыт организации домашнего парентерального питания детей в Санкт-Пете...rnw-aspen
Доклад с XVI Межрегиональной научно-практической конференции "Искусственное питание и инфузионная терапия больных в медицине критических состояний" 21-22 апреля 2016 г.
"Хронический интестинальный псевдообструктивный синдром: современные тренды д...rnw-aspen
Доклад с XVI Межрегиональной научно-практической конференции "Искусственное питание и инфузионная терапия больных в медицине критических состояний" 21-22 апреля 2016 г.
"Альбумин в интенсивной терапии критических состояний у детей" Пшениснов К.В...rnw-aspen
Доклад с XVI Межрегиональной научно-практической конференции "Искусственное питание и инфузионная терапия больных в медицине критических состояний" 21-22 апреля 2016 г.
"Синтетические коллоиды в интенсивной терапии шока у детей. За и против?" Ал...rnw-aspen
Доклад с XVI Межрегиональной научно-практической конференции "Искусственное питание и инфузионная терапия больных в медицине критических состояний" 21-22 апреля 2016 г.
Различные варианты сосудистого доступа для пациентов, получающих прентерально...rnw-aspen
Доклад с XVI Межрегиональной научно-практической конференции "Искусственное питание и инфузионная терапия больных в медицине критических состояний" 21-22 апреля 2016 г.
"Проблемные вопросы полного парентерального питания больных в клинической пра...rnw-aspen
Доклад с XVI Межрегиональной научно-практической конференции "Искусственное питание и инфузионная терапия больных в медицине критических состояний" 21-22 апреля 2016 г.
"Синдром короткой кишки у детей: нутритивная поддержка до и после аутологичны...rnw-aspen
Доклад с XVI Межрегиональной научно-практической конференции "Искусственное питание и инфузионная терапия больных в медицине критических состояний" 21-22 апреля 2016 г.
"Синдром короткой кишки - проблемы лечения и возможные перспективы" Луфт В....rnw-aspen
Доклад с XVI Межрегиональной научно-практической конференции "Искусственное питание и инфузионная терапия больных в медицине критических состояний" 21-22 апреля 2016 г.
"Нутритивно-метаболическая терапия при ОРДС: обсуждаем спорные моменты" Ярош...rnw-aspen
Доклад с XVI Межрегиональной научно-практической конференции "Искусственное питание и инфузионная терапия больных в медицине критических состояний" 21-22 апреля 2016 г.
"Клиническая демонстрация больного с осложненным течением острого деструктивн...rnw-aspen
Доклад с XVI Межрегиональной научно-практической конференции "Искусственное питание и инфузионная терапия больных в медицине критических состояний" 21-22 апреля 2016 г.
"Метаболическая дисфункция при сепсисе: клинические проявления и подходы к ко...rnw-aspen
Доклад с XVI Межрегиональной научно-практической конференции "Искусственное питание и инфузионная терапия больных в медицине критических состояний" 21-22 апреля 2016 г.
"Сепсис: новые взгляды на старую проблему" Кулабухов В.В., Руднов В.А. (Москва)rnw-aspen
Доклад с XVI Межрегиональной научно-практической конференции "Искусственное питание и инфузионная терапия больных в медицине критических состояний" 21-22 апреля 2016 г.
"Инфузионная и нутритивная терапия больных с острым панкреатитом" Соботка Л....rnw-aspen
Доклад с XVI Межрегиональной научно-практической конференции "Искусственное питание и инфузионная терапия больных в медицине критических состояний" 21-22 апреля 2016 г.
"Проблемные вопросы инфузионной терапии острого панкреатита" Афончиков В.С...rnw-aspen
Доклад с XVI Межрегиональной научно-практической конференции "Искусственное питание и инфузионная терапия больных в медицине критических состояний" 21-22 апреля 2016 г.
PGx Analysis in VarSeq: A User’s PerspectiveGolden Helix
Since our release of the PGx capabilities in VarSeq, we’ve had a few months to gather some insights from various use cases. Some users approach PGx workflows by means of array genotyping or what seems to be a growing trend of adding the star allele calling to the existing NGS pipeline for whole genome data. Luckily, both approaches are supported with the VarSeq software platform. The genotyping method being used will also dictate what the scope of the tertiary analysis will be. For example, are your PGx reports a standalone pipeline or would your lab’s goal be to handle a dual-purpose workflow and report on PGx + Diagnostic findings.
The purpose of this webcast is to:
Discuss and demonstrate the approaches with array and NGS genotyping methods for star allele calling to prep for downstream analysis.
Following genotyping, explore alternative tertiary workflow concepts in VarSeq to handle PGx reporting.
Moreover, we will include insights users will need to consider when validating their PGx workflow for all possible star alleles and options you have for automating your PGx analysis for large number of samples. Please join us for a session dedicated to the application of star allele genotyping and subsequent PGx workflows in our VarSeq software.
STUDIES IN SUPPORT OF SPECIAL POPULATIONS: GERIATRICS E7shruti jagirdar
Unit 4: MRA 103T Regulatory affairs
This guideline is directed principally toward new Molecular Entities that are
likely to have significant use in the elderly, either because the disease intended
to be treated is characteristically a disease of aging ( e.g., Alzheimer's disease) or
because the population to be treated is known to include substantial numbers of
geriatric patients (e.g., hypertension).
Giloy in Ayurveda - Classical Categorization and SynonymsPlanet Ayurveda
Giloy, also known as Guduchi or Amrita in classical Ayurvedic texts, is a revered herb renowned for its myriad health benefits. It is categorized as a Rasayana, meaning it has rejuvenating properties that enhance vitality and longevity. Giloy is celebrated for its ability to boost the immune system, detoxify the body, and promote overall wellness. Its anti-inflammatory, antipyretic, and antioxidant properties make it a staple in managing conditions like fever, diabetes, and stress. The versatility and efficacy of Giloy in supporting health naturally highlight its importance in Ayurveda. At Planet Ayurveda, we provide a comprehensive range of health services and 100% herbal supplements that harness the power of natural ingredients like Giloy. Our products are globally available and affordable, ensuring that everyone can benefit from the ancient wisdom of Ayurveda. If you or your loved ones are dealing with health issues, contact Planet Ayurveda at 01725214040 to book an online video consultation with our professional doctors. Let us help you achieve optimal health and wellness naturally.
Pictorial and detailed description of patellar instability with sign and symptoms and how to diagnose , what investigations you should go with and how to approach with treatment options . I have presented this slide in my 2nd year junior residency in orthopedics at LLRM medical college Meerut and got good reviews for it
After getting it read you will definitely understand the topic.
Nutritional deficiency Disorder are problems in india.
It is very important to learn about Indian child's nutritional parameters as well the Disease related to alteration in their Nutrition.
TEST BANK For Brunner and Suddarth's Textbook of Medical-Surgical Nursing, 14...Donc Test
TEST BANK For Brunner and Suddarth's Textbook of Medical-Surgical Nursing, 14th Edition (Hinkle, 2017) Verified Chapter's 1 - 73 Complete.pdf
TEST BANK For Brunner and Suddarth's Textbook of Medical-Surgical Nursing, 14th Edition (Hinkle, 2017) Verified Chapter's 1 - 73 Complete.pdf
TEST BANK For Brunner and Suddarth's Textbook of Medical-Surgical Nursing, 14th Edition (Hinkle, 2017) Verified Chapter's 1 - 73 Complete.pdf
Computer in pharmaceutical research and development-Mpharm(Pharmaceutics)MuskanShingari
Statistics- Statistics is the science of collecting, organizing, presenting, analyzing and interpreting numerical data to assist in making more effective decisions.
A statistics is a measure which is used to estimate the population parameter
Parameters-It is used to describe the properties of an entire population.
Examples-Measures of central tendency Dispersion, Variance, Standard Deviation (SD), Absolute Error, Mean Absolute Error (MAE), Eigen Value
Travel Clinic Cardiff: Health Advice for International TravelersNX Healthcare
Travel Clinic Cardiff offers comprehensive travel health services, including vaccinations, travel advice, and preventive care for international travelers. Our expert team ensures you are well-prepared and protected for your journey, providing personalized consultations tailored to your destination. Conveniently located in Cardiff, we help you travel with confidence and peace of mind. Visit us: www.nxhealthcare.co.uk
3. • Mrs. Van der G., 62 years old, 1.68 m, 58 kg
• no serious comorbidity, admitted to the emergency ward
elsewhere
• abdominal pain for 3 days, vomiting and no passage of
stools since three days, no fever.
• Medical history
• Hysterectomy (removal of the uterus) 20 years earlier
because of uncontrollable meno-, metrorhagies (bleeding).
• Since years recurrent crampy pain and slight bowel
distention with audible bowel sounds. This has been
become worse and at times she has been anorectic.
• Physical examination
• Slight distension of the abdomen, no bowel sounds
• Tenderness and rebound tenderness in the abdomen but
especially in the left upper quadrant .
• Clinically dehydrated.
• Plain X-ray films of the abdomen in standing position:
5. P.o. day -2 y to -9
At Home
-1d
Elsewhere
9d
MUMC
25d
MUMC
50d
MUMC
Hb mmol
N ± 7.3 – 8
7,1
Leuco’s/fl 23
Alb g/L
N ± 40
31
Kreat µM/L
N ± 80
153
BW kg 66-58 60
• Is the Hb normal?
• Is she malnourished?
6. What is Malnutrition?
A nutritional state resulting from a
combination of varying degrees of
undernutrition and inflammatory
activity and leading to abnormal
body composition and diminished
function
7. Three types of function = Quality of Life
•Muscle function
•Strength
•Reservoir of substrate to support an
adequate metabolic response to
trauma/disease
•Immune function
•Allowing to generate an inflammatory (=
healing) response
•Cognitive function
•To allow thinking, remembering, feeling
well, managing life etc
10. P.o. day -2 y to -9
At Home
-1d
Elsewhere
9d
MUMC
25d
MUMC
50d
MUMC
Hb mmol 7,1
Leuco’s/fl 23
Alb g/L 31
Kreat µM/L 153
BW kg 66-58 60
?
Why does Bodyweight (BW) increase from 58 to 60 kg?
11. Mrs. van der G., 62 y old at the emergency ward
Questions:
•Mrs. van der G. is dehydrated. How do you
rehydrate her?
•Mrs. van der G. is malnourished
•Does she need an operation and if so does
she need preoperative nutrition? Or is she
so ill that she needs an operation acutely?
12. After 6 hours of preparation (rehydration, nasal tube
suction, high rectal enema):
• No improvement of bowel function
• Immediate operation
• Volvulus of one of the first loops of the jejunum, necrotic.
• Generalized peritonitis.
• Resection of the loop (50 cm) and primary anastomosis.
Questions:
• Is this wise?
• Would you have done something differently?
• Which nutritional regimen do you prescribe and when should this be
started?
• Would you have created a gastrostomy or jejunostomy to feed?
13. Immediate postoperative course
• No improvement, patient remains ill
• Much fluid support is necessary to keep urine production up
• Fever
• Nasal stomach tube: approximately 1600 ml/24h comes out
• Tube feeding is impossible.
• After 5 days the midline incision opens due to a wound
abscess; dehiscence of the abdominal wall.
• Development of an acute respiratory insufficiency.
9 days after operation she is transferred to the Maastricht
University Medical Centre (MUMC), the Netherlands to the
ICU.
14. What are the priorities of treatment?
SOWATS guideline
•Treatment concept
•Sepsis control
•Optimization of nutritional state
•Wound care
•Anatomy of the fistula
•Timing of surgery
•Surgical strategy
Visschers, R. G., et al. (2008). "Treatment strategies in 135 consecutive patients with
enterocutaneous fistulas." World J Surg 32(3): 445-453.
15. •She barely escapes artificial ventilation.
•A CT scan is made of the abdomen.
SOWATS guideline: Sepsis control
16.
17. Mrs. van der G., 62 y old, 9 days after operation
•CT scan abdomen: intra-abdominal abscess.
•Abcess drainage via a small surgical incision after
radiologic puncture drainage had failed
•A day later:
• Discharge of bile through the small wound.
• In a few days a high output fistula develops (over 1500
ml per day) draining like a loop jejunostomy.
• The fistula arose from lesions caused by the dissection of
inflamed intestine (peritonitis) or from the anastomosis
during the earlier operation.
•Questions:
•How do you nourish her?
•Which nutrients can still be adequately absorbed in
the 50 cm of intact jejunum that is still in
continuity with the oesophagus, stomach and
19. In the two following weeks (3 ½ weeks
after admittance) almost all organ
functions improve (Improvement of
respiratory and renal function, and
discontinuation of inotropic support)
Fistula output increases to 2000-2500
ml/24h.
20. P.o. day -2 y to -10
At Home
-1d
Elsewhere
9d
MUMC
25d
MUMC
50d
MUMC
Hb mmol 7,1 5,6 6,7
Leuco’s/fl 23 18 11
Alb g/L 31 15 23
Kreat µM/L 153 120 56
BW kg 66-58 60 65 56
Why does albumin increase?
Why does the body weight decrease?
21. •In the two following weeks (3 ½ weeks after
admittance) almost all organ functions improve
(Improvement of respiratory and renal function,
and discontinuation of inotropic support) Fistula
output increase to 2000-2500 ml/24h. But ………..
Mrs vd G. gets jaundiced (yellow skin).
• Alk Phosphatase 4x elevated
• GT 4x elevated
• Direct Bilirubin 230 µmol
• Transaminases slightly elevated
• Triglyceride levels 3-4 mmol
• Inflammatory parameters modest inflammation.
• Albumin > 23 g/l without Albumin infusion.
24. Rinsema et al, SGO 1988
Rinsema W, Gouma DJ, von Meyenfeldt MF, Soeters PB. Reinfusion of secretions from
high-output proximal stomas or fistulas. Surg Gynecol Obstet. 1988;167(5):372-6.
25. Activation of the Nuclear bile acid receptor
(Farnesoid receptor; FXR) with bile :
• Diminishes intestinal inflammation, liver cholestasis and
steatosis when activated by
• Re-establishing primary bile acid pool by
operation/reinfusion or UDCA, CA, norUDCA
• Synthetic FXR activators
• Improves intestinal integrity
• Decreases Triglyceride and Cholesterol content in the liver
and VLDL assemby
• FXR deletion/ malfunction increases fat content of the liver
26. Nutritional support:
• 1000 ml of enteral formula feeding per day together with a large part
of the proximal pancreatic and biliary secretions.
• PN is diminished to 1000 ml/d without lipid.
• 2x/week 500 ml 10% lipid emulsion
• 0,5-1.0 litres of balanced salt solution supplemented with Mg, Ca, Zn
=> electrolytes normalize.
After three weeks:
• Alk Phosphatase High range of normal
• Gamma- GT High range of normal
• Direct Bilirubin 20 µmol (high range of normal)
• Transaminases Normal
• Triglyceride levels 1-2 mmol (2x/week 500 ml 10% lipid
emulsion)
• Inflammatory parameters CRP 20 mg/L
• Albumin > 25 g/l without Albumin infusion.
27. P.o. day -2 y to -10
At Home
-1d
Elsewhere
9d
MUMC
25d
MUMC
50d
MUMC
Hb mmol 7,1 5,6 6,7 7,8
Leuco’s/fl 23 18 11 7,5
Alb g/L 31 15 23 32
Kreat µM/L 153 120 56 63
BW kg 66-58 60 65 56 56
Why does she not gain weight?
How does her body composition change?
28. •Physical, cognitive and biochemical improvement.
•Alb, Hb, rise.
•Intrahepatic cholestasis/jaundice disappear
completely.
•35 days after operation transfer from ICU to normal
ward.
•Physiotherapy was started in ICU and continued in
physiotherapy ward.
• 56 days after her first operation reoperation:
•Jejunal fistula is closed
•Abdominal wound is closed. The skin is left open.
•Mrs B. resumes oral intake a few days after the
operation and is discharged 70 days after her
admittance to the ICU.
29. SOWATS: Optimization of nutritional state
•± 70% of fistula patients are severely
malnourished
•Inadequate food intake and malabsorption
•Catabolism due to inflammation/infection
•Short bowel
•Malnutrition leads to:
•Bad healing of wounds
•Bad healing of anastomoses
•Lack of bile in the bowel leads to
inflammation in the bowel and in the liver
30. SOWATS: Optimization of nutritional state
•Total parenteral nutrition when fistula may
heal spontaneously; some enteral (500 ml)
•Always enteral if possible:
•when fistula will not heal spontaneously
•when fistula output does not damage the
wound
•add parenteral nutrition when not enough
enteral can be given or absorbed
•Physiotherapy
31. Development of enterocutaneous fistula
Spontaneous or surgical perforation => abcess
=> rupture/drainage abscess to skin or other
organ=> fistula
Formation Cause
Spontaneous
10-25%
Crohn’s disease
Cancer
Diverticulitis
Radiation enteritis
Surgical
75-90%
Iatrogenic lesion (sutures)
Anastomotic failure
Abdominal wall dehiscence
Mesh rupture
Drain puncture
Traumatic
<5%
Diagnostic intervention (puncture)
(Traffic) accident
Gun shot wound
Knife injury
33. Mortality in fistulas
•In the past:
•Sepsis
•Lack of nutritional support
•Fluid and electrolyte imbalance (especially
in the past)
•At present:
•Sepsis
34. Advances in treatment
•Parenteral/Enteral nutrition techniques
•Intensive care medicine
•Surgical technique
•Radiology (Ct and others) and
intervention
•Intestinal failure unit/ teams
•Management skills
35. Current treatment strategy
•There are no randomized controlled trials
(possible) but treatment is based on
cohort studies, case reports and expert
opinion from specialized referral centers
•Development of standardized treatment
strategies (protocol/guidelines)
36. SOWATS: Sepsis leading to organ disfunction
and malnutrition
•Most often cause of death in fistula patients
•Often due to inadequate drainage
•Treatment first priority
•Preferably CT-guided puncture of abscesses
•Prevent complete laparotomy if possible
because of many complications at this
moment
•Only antibiotics have little effect, should be
based on cultures but are ineffective in the
presence of major abscesses.
37. Diagnosis fistula in case of fluid
drainage of unknown origin
•Food substances (e.g. fiber)
•High concentrations of bilirubin/amylase
•Puncture abdominal fluid:
•Gram stain and culture
•Alb (low when intestinal content)
•Creat, amylase, bilirubin
•Cytology when malignancy possible
•Radiology
38. Signs of sepsis improvement
•Patients feel better
•No fever
•Disappearance of edema/ drying up
•Negative fluid balance
•Wrinkling of the skin
•Interest in surroundings
•Much stronger, gets out of bed
•Becomes impatient, wants to be operated
•Hb, Alb increase
•CRP, Sedimentation rate, Leucocytes decrease
39. Enteral Nutrition
•How much bowel is necessary to take up
enough nutrition by enteral route?
•> 200 cm small bowel without colon
•> 50-150 cm small bowel with colon
•When long segment (75-100 cm) distal small
bowel excluded:
•Re-infusion of (high) output from the
entero-cutaneous fistula
40. Parenteral nutrition
•Main goal:
•Maximize nutritional status
•Decrease fistula output by limiting
enteral nutrition
•Bridging to surgical closure
•Makes wound care easier
•Allows easier spontaneous closure
41. SOWATS: Wound care
•Low output < 500 ml, high output > 500 ml/day
•Intestinal fluid loss = loss of fluid and electrolytes
•Proteolytic activity of intestinal enzymes requires:
•In small wounds with low output fistula barrier and
keeping skin dry
•Large abdominal wall defects with high output fistulas
treatment with wound bags and sump suction drainage
•No vacuum devices on exposed bowel
•Proton pump inhibitors to diminish gastric secretion
•No significant effects of Somatostatin analogues
•Motility inhibitors (Imodium, Loperamide)
42. Wound care (of another patient)
• Daily inspection and care
• Stoma / wound care nurses
Day 0 Day 0 Day 7 Day 49
44. Spontaneous closure
Overall spontaneous
closure rate 20-30%
•Usually occurs
within 30 days after
development of the
fistula
•When spontaneous
closure does not
occur surgical
treatment is
generally needed
Negative predictors
for spontaneous
closure
• Major dehiscence of the
anastomosis
• Short fistula tract
• Distal obstruction
• Epithelialised fistula tract
• Sepsis or nearby abscess cavity
• High output ECF
• Chronic ECF
• Fistula in an open abdominal
wound
• Non-surgical cause
• Referrals
• Jejuno-ileal ECF
45. SOWATS: Timing of surgery
•Wait at least 6-12 weeks before performing
restorative surgery to allow the abdomen to
become accessible again
•Sepsis should be controlled
•Dry, loss of edema, wrinkling of the skin
•Biochemical parameters (albumin > > 25
g/L)
•Adequate nutritional status
•Clinical parameters (muscle, immune,
cognition)
46. SOWATS: Surgical closure
•Performed in 60-80% of patients
•Successful in 85-90% of cases in centers
•45-70% of the overall closure rate
•Resection of fistula tract and diseased bowel
•Reconnection of the intestine
•Sutures surrounded by healthy tissue, not
exposed to other suture lines or wound
closure
•Closure of the abdominal wall with fascia or
Vicryl mesh
47. Overview reviewed/ treated series
0
10
20
30
40
50
60
70
80
90
100
'46-'59 '60-'70 '70-'75 '77-'87 '90-'05
reviewed period
%patients
mortality overall closure rate (%)
Edmunds, Williams, Welch: Ann. Surg. 1960
Soeters, Fischer, Franklin: Arch. Chir. Neerl. 1977
Soeters, Ebeid, Fischer: Ann. Surg. 1979
Rinsema, Gouma, von Meyenfeldt, van der Linden, Soeters: Acta Chir. Scand. 1990
Visscher, Olde Damink, Winkens, Soeters, van Gemert: Ann. Surg. 2008
157 119 404 114 135
48. 9 days after operation the following lab parameters are found:
• Hb 5.6 mmol/L
• ESR 36 mm/first hour
• Leucocytes 18/ fliter
• CRP 115 mg/l
• Kreat 120 mol/l
• Albumin 15 g/l
• BUN 9 mmol/l
• Electrolytes
• Na 128 mmol/l
• K 5.6 mmol/l
• Cl 115 mmol
• Liver enzymes
• AF and GTP Slightly elevated
• Transaminases normal
• Bilirubin 19 μmol/l
• Ca 1.7 mmol/l
• Mg 0.41 mmol/l
• Zn 7 mol/l
• Cu 39 mol/l
• Fe 8 mol/l
• Transferrin 2.80 mmol/l
• Triglycerides 2.3 mmol/l
49. Conclusion
•Patients with abdominal catastrophe/
enterocutaneous fistula suffer from multiple
complications
•Treatment is complex and requires
multidisciplinary expertise
•SOWATS approach is necessary
•Consider nutritional and metabolic complications
•Treat sepsis, institute nutrition and
physiotherapy: are crucial elements of treatment
•Timing and art of surgery are also important
•One captain and one deputy captain on the ship